Market Closed -
Other stock markets
|
|
Pre-market 01:55:41 am | ||
18.36 EUR | -0.66% | 18.27 | -0.47% |
Dec. 06 | European Equities Traded in the US as American Depositary Receipts Rise Modestly in Wednesday | MT |
Dec. 05 | PHILIPS NV : JP Morgan gives a Sell rating | ZD |
Sales 2023 * | 18.49B 19.91B | Sales 2024 * | 19.3B 20.78B | Capitalization | 16.82B 18.1B |
---|---|---|---|---|---|
Net income 2023 * | -233M -251M | Net income 2024 * | 906M 975M | EV / Sales 2023 * | 1,25x |
Net Debt 2023 * | 6.38B 6.86B | Net Debt 2024 * | 5.77B 6.21B | EV / Sales 2024 * | 1,17x |
P/E ratio 2023 * | -90,0x | P/E ratio 2024 * | 18,9x | Employees | 71,519 |
Yield 2023 * | 4,78% | Yield 2024 * | 5,07% | Free-Float | 83.96% |
More Fundamentals
* Assessed data
More news
More press releases
1 day | -0.66% | ||
1 week | -6.06% | ||
Current month | -2.18% | ||
1 month | -4.49% | ||
3 months | -9.58% | ||
6 months | +2.18% | ||
Current year | +36.96% |
1 week
18.08
19.21

1 month
18.03
19.74

Current year
13.48
20.94

1 year
11.70
20.94

3 years
11.61
48.80

5 years
11.61
48.80

10 years
11.61
48.80

Managers | Title | Age | Since |
---|---|---|---|
Roy Jakobs
CEO | Chief Executive Officer | 49 | 2009 |
Director of Finance/CFO | 62 | 1986 | |
Shez Partovi
CTO | Chief Tech/Sci/R&D Officer | 56 | 2021 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Pyott
BRD | Director/Board Member | 69 | 2014 |
Sanjay Poonen
BRD | Director/Board Member | 54 | 2021 |
Director/Board Member | 67 | 2021 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
3.26% | 182 M€ | +13.45% | ||
3.00% | 262 M€ | +12.91% | ||
2.34% | 19 M€ | +14.83% | - |
Date | Price | Change | Volume |
---|---|---|---|
23-12-06 | 18.36 | -0.66% | 2,919,983 |
23-12-05 | 18.48 | -1.76% | 2,206,370 |
23-12-04 | 18.81 | +0.11% | 2,383,638 |
23-12-01 | 18.79 | +0.13% | 1,838,972 |
23-11-30 | 18.77 | -0.31% | 14,997,290 |
Real-time Euronext Amsterdam, December 06, 2023 at 11:35 am EST
More quotes
Koninklijke Philips N.V. is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. The group leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Koninklijke Philips N.V. is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care.
Calendar
2023-12-10
- Investor Meeting - Barclays
Trading Rating :
Investor Rating :
ESG Refinitiv :
B
Sell
Buy

Mean consensus
HOLD
Number of Analysts
18
Last Close Price
18.36EUR
Average target price
19.73EUR
Spread / Average Target
+7.46%
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+36.96% | 18 272 M $ | |
-10.33% | 190 B $ | |
-16.83% | 162 B $ | |
+16.92% | 109 B $ | |
+18.48% | 80 398 M $ | |
+12.56% | 63 226 M $ | |
-10.80% | 48 897 M $ | |
-6.86% | 41 758 M $ | |
-13.86% | 37 357 M $ | |
+16.56% | 30 925 M $ |